CN106256359A - 一种麻醉科用于治疗癌性疼痛的药物组合物 - Google Patents
一种麻醉科用于治疗癌性疼痛的药物组合物 Download PDFInfo
- Publication number
- CN106256359A CN106256359A CN201610780070.2A CN201610780070A CN106256359A CN 106256359 A CN106256359 A CN 106256359A CN 201610780070 A CN201610780070 A CN 201610780070A CN 106256359 A CN106256359 A CN 106256359A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- pharmaceutical composition
- treating
- anesthesia department
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002193 Pain Diseases 0.000 title claims abstract description 58
- 230000036407 pain Effects 0.000 title claims abstract description 58
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 38
- 206010002091 Anaesthesia Diseases 0.000 title claims abstract description 30
- 230000037005 anaesthesia Effects 0.000 title claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims abstract description 40
- 241000722823 Armadillidium Species 0.000 claims abstract description 20
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 20
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 20
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 20
- 229910021538 borax Inorganic materials 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 19
- 241000660877 Coridius Species 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 241000628997 Flos Species 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 14
- 235000007164 Oryza sativa Nutrition 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 235000009566 rice Nutrition 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 235000020681 well water Nutrition 0.000 claims description 12
- 239000002349 well water Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 238000002386 leaching Methods 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- 238000012859 sterile filling Methods 0.000 claims description 7
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 7
- 238000009423 ventilation Methods 0.000 claims description 7
- 238000004321 preservation Methods 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 12
- 231100000614 poison Toxicity 0.000 abstract description 10
- 230000008961 swelling Effects 0.000 abstract description 10
- 239000003440 toxic substance Substances 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 201000011510 cancer Diseases 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 206010058019 Cancer Pain Diseases 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 206010013663 drug dependence Diseases 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 208000011117 substance-related disease Diseases 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000003902 lesion Effects 0.000 abstract description 2
- 239000002398 materia medica Substances 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 241000209094 Oryza Species 0.000 description 11
- 206010000087 Abdominal pain upper Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- ZQBMUHABRSEAIK-UXBLZVDNSA-N 1-[4-[(e)-3-phenylprop-2-enyl]piperazin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CCC)CCN1C\C=C\C1=CC=CC=C1 ZQBMUHABRSEAIK-UXBLZVDNSA-N 0.000 description 1
- JASVNTDJKFETNC-UHFFFAOYSA-N 16-Methoxystrychnine Natural products C=1C=CC=C2C=1N1C(=O)CC3OCC=C4CN5C6C(OC)C4C3C1C62CC5 JASVNTDJKFETNC-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 206010016173 Fall Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940120889 dipyrone Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种麻醉科用于治疗癌性疼痛的药物组合物,由以下按照重量份的原料制成:合欢花10‑20份、尖尾风15‑25份、紫苏叶4‑10份、两面针6‑12份、九香虫4‑8份、独活5‑15份、吕宋果4‑8份、三七10‑20份、天仙子8‑12份、红木香7‑13份、硼砂4‑6份、鼠妇1‑5份;本发明的药物诸药配伍合宜,符合中药学君臣配伍以及现代药理学,具有清热解毒、活血化瘀、理气止痛、解毒消肿的功效,能有效缓解癌症疼痛,疗效好、无副作用,无药物依赖性、用药成本低,能使药物直达病灶部位,增强癌症治疗效果,降低患者治疗过程中的不适感,提高患者免疫力,具有极大的临床推广价值。
Description
技术领域
本发明涉及医药技术领域,具体是一种麻醉科用于治疗癌性疼痛的药物组合物。
背景技术
慢性癌痛是由于恶性肿瘤引起的慢性疼痛,癌症病人的自觉症状中,疼痛发生率最高;有25-40%初诊的恶性肿瘤患者、30-50%的癌症患者在积极治疗期间、70%-90的患者在癌症进展期都会出现这一症状,许多癌症病人在生命的最后一段时间内不得不忍受着癌痛的极大痛苦,药物治疗是癌痛治疗的主要方法,麻醉科目前治疗癌痛的方法由局部治疗、镇痛药剂阻断疼痛的传导途径等;目前的止痛药有偶阿司匹林、强痛定、安乃近、消炎痛等,但对癌痛疗效欠佳,夜勤消化道反应及骨髓抑制等副反应而不能长期应用;麻醉止痛剂有可待因、杜冷丁,虽然暂时缓解癌性疼痛,但是易引起药物依赖性,且需求量越来越大,间隔时间越来越短;基于上述原因,需要研发新的用于治疗癌性疼痛的麻醉科药物,以满足癌症患者的使用需求。
发明内容
本发明的目的在于提供一种疗效好、无药物依赖性、用药成本低的用于治疗癌性疼痛的药物组合物,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种麻醉科用于治疗癌性疼痛的药物组合物,由以下按照重量份的原料制成:合欢花10-20份、尖尾风15-25份、紫苏叶4-10份、两面针6-12份、九香虫4-8份、独活5-15份、吕宋果4-8份、三七10-20份、天仙子8-12份、红木香7-13份、硼砂4-6份、鼠妇1-5份。
作为本发明进一步的方案:所述麻醉科用于治疗癌性疼痛的药物组合物,由以下按照重量份的原料制成:合欢花13-17份、尖尾风18-22份、紫苏叶6-8份、两面针8-10份、九香虫5-7份、独活9-11份、吕宋果5-7份、三七11-19份、天仙子9-11份、红木香9-11份、硼砂4-6份、鼠妇2-4份。
作为本发明再进一步的方案:所述麻醉科用于治疗癌性疼痛的药物组合物,由以下按照重量份的原料制成:合欢花15份、尖尾风20份、紫苏叶7份、两面针8份、九香虫6份、独活10份、吕宋果6份、三七15份、天仙子10份、红木香10份、硼砂5份、鼠妇3份。
作为本发明再进一步的方案:所述麻醉科用于治疗癌性疼痛的药物组合物的制备方法,包括以下步骤:
1)按配方称取各原料,洗净晾干后备用;
2)将九香虫、硼砂、鼠妇、三七研磨成400-600目细粉,并置于混合细粉3-5倍重量、体积分数为95%的乙醇溶液中浸泡20-30h,采用CO2超临界萃取技术分离上清液备用;
3)将合欢花、尖尾风、紫苏叶、两面针混合后加入混合物总重量6-10倍的水,武火煮沸后,保持沸腾状态1-2h,过滤取煎煮液自然冷却后备用;
4)将独活、吕宋果、天仙子、红木香采用粉碎机粉碎后置于反应罐中,加入物料重量4-8倍的水,于60-80℃条件下熬制46-50h,熬制结束后过滤,取滤液备用;
5)将步骤2)中的上清液、步骤3)中的煎煮液以及步骤4)中的滤液混合浓缩,混合液浓缩至原体积的1/5后,冷冻干燥,并粉碎研磨至200-300目,得本发明药物组合物。
5.根据权利要求4所述的麻醉科用于治疗癌性疼痛的药物组合物的制备方法,其特征在于,所述步骤3)、步骤4)中的水取自底下60-100米深的井水。
作为本发明再进一步的方案:所述步骤3)中,煎煮温度为95-100℃,水的pH值为7.0-8.0。
作为本发明再进一步的方案:所述步骤4)中,滤液采用无菌灌装后,置于阴凉通风处保存7-15d备用。
作为本发明再进一步的方案:所述步骤5)中,混合溶液以800-1000r/min的搅拌速度搅拌30-45min,搅拌过程中维持恒温50-60℃。
作为本发明再进一步的方案:所述药物组合物通过添加药学上常规辅料制备成用于治疗癌性疼痛的外敷剂或针剂。
本发明中各药物的药理作用如下:
1.合欢花:味甘,性平;舒郁、理气、安神、活络、养血、滋阴肾、清心明目;合欢花含有合欢甙,鞣质,解郁安神,滋阴补阳,理气开胃,活络止痛,用于、忧郁失眠;治郁结胸闷,失眠,健忘,风火眼,能安五脏,和心志,悦颜色,有较好的强身、镇静、安神、美容的作用,是治疗神经衰弱的佳品。具有清热解暑,养颜祛斑解酒等功效。
2.尖尾风:味辛、微苦;性温;祛风散寒,散瘀止血,解毒消肿;用于风寒咳嗽,寒积腹痛,风湿痹痛,跌打损伤,内外伤出血,无名肿毒。
3.紫苏叶:味辛,性微温,无毒;归脾经、肺经;芳香升散,具有散寒解表,宣肺止咳,理气和中,安胎,解毒;主治外感风寒,恶寒发热,头痛无汗,咳嗽气喘,脘腹胀闷,呕恶腹泻,咽中梗阻,妊娠恶阻,胎动不安,食鱼蟹中毒,痈疮蛇毒辣。
4.两面针:味苦、辛,性平;归肝、胃经;活血化瘀,行气止痛,祛风通络,解毒消肿;用于跌扑损伤,胃痛,牙痛,风湿痹痛,毒蛇咬伤;外治烧烫伤。
5.九香虫:味咸;性温;无毒;归肝、脾、肾经;理气止痛,温中助阳。用于胃寒胀痛,肝胃气痛,肾虚阳痿,腰膝酸痛。
6.独活:味辛、苦;性微温;归肾、膀胱经;祛风除湿,通痹止痛。用于风寒湿痹,腰膝疼痛,少阴伏风头痛。
7.吕宋果:味苦,性寒;种子含生物碱2.5~5%,其中46~62%为番木鳖碱;还有马钱子碱0.5%、少量的小檗碱以及三个16-烷氧基番木鳖碱:16-甲氧基番木鳖碱、16-乙氧基番木鳖碱和16-丙氧基番木鳖碱;理气止痢,截疟,止血解毒,杀虫。治腹痛泻痢,疟疾,刀伤出血,蛇、蝎、蜈蚣咬伤,虫积。
8.三七:味甘、微苦;性温;散瘀止血,消肿定痛;用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛。
9.天仙子:味苦、辛,性温;入心、胃、肝三经;具有解痉、止痛、安神、杀虫的作用;治癫狂,风癎,风痹厥痛,喘咳,胃痛,久痢,久泻,脱肛,牙痛,痈肿,恶疮。
10.红木香:味辛,性温;果实含挥发浊、有机酸、蛋白质、脂肪油、粘液质、果胶;行气,活血,止痛;治气滞腹胀痛,胃痛,筋骨疼痛,月经痛,跌打损伤,无名肿毒。
11.硼砂:味甘、咸,性凉;归肺、胃经;外用清热解毒,消肿,防腐;内服清肺化痰;用于急性扁桃体炎,咽喉炎,咽喉肿痛,口舌生疮,口腔炎,齿龈炎,中耳炎,目赤肿痛,汗斑,为五官科疾患的常用药,内服用于痰热咳嗽,噎隔。
12.鼠妇:味酸;性温;无毒;破血,利水,解毒,止痛。治久疟疟母,经闭症瘕,小便不通,惊风撮口,口齿疼痛,鹅口诸疮。
与现有技术相比,本发明的有益效果是:本发明的药物诸药配伍合宜,符合中药学君臣配伍以及现代药理学,具有清热解毒、活血化瘀、理气止痛、解毒消肿的功效,能有效缓解癌症疼痛,疗效好、无副作用,无药物依赖性、用药成本低,能使药物直达病灶部位,增强癌症治疗效果,降低患者治疗过程中的不适感,提高患者免疫力,具有极大的临床推广价值。
具体实施方式
下面结合具体实施方式对本专利的技术方案作进一步详细地说明。
实施例1
一种麻醉科用于治疗癌性疼痛的药物组合物,由以下按照重量份的原料制成:合欢花10份、尖尾风15份、紫苏叶4份、两面针6份、九香虫4份、独活5份、吕宋果4份、三七10份、天仙子8份、红木香7份、硼砂4份、鼠妇1份。
所述麻醉科用于治疗癌性疼痛的药物组合物的制备方法,包括以下步骤:
1)按配方称取各原料,洗净晾干后备用;
2)将九香虫、硼砂、鼠妇、三七研磨成400-600目细粉,并置于混合细粉3倍重量、体积分数为95%的乙醇溶液中浸泡20h,采用CO2超临界萃取技术分离上清液备用;
3)将合欢花、尖尾风、紫苏叶、两面针混合后加入混合物总重量6倍的水,水取自底下60-100米深的井水,水的pH值为7.0-8.0,武火煮沸后,保持沸腾状态1h,煎煮温度为95-100℃,过滤取煎煮液自然冷却后备用;
4)将独活、吕宋果、天仙子、红木香采用粉碎机粉碎后置于反应罐中,加入物料重量4倍的水,水取自底下60-100米深的井水,于60℃条件下熬制46h,熬制结束后过滤,取滤液,采用无菌灌装后,置于阴凉通风处保存7d备用;
5)将步骤2)中的上清液、步骤3)中的煎煮液以及步骤4)中的滤液混合浓缩,混合溶液以800r/min的搅拌速度搅拌30min,搅拌过程中维持恒温50℃;混合液浓缩至原体积的1/5后,冷冻干燥,并粉碎研磨至200目,得本发明药物组合物,物组合物通过添加药学上常规辅料制备成用于治疗癌性疼痛的外敷剂。
实施例2
一种麻醉科用于治疗癌性疼痛的药物组合物,由以下按照重量份的原料制成:合欢花20份、尖尾风25份、紫苏叶10份、两面针12份、九香虫8份、独活15份、吕宋果8份、三七20份、天仙子12份、红木香13份、硼砂6份、鼠妇5份。
所述麻醉科用于治疗癌性疼痛的药物组合物的制备方法,包括以下步骤:
1)按配方称取各原料,洗净晾干后备用;
2)将九香虫、硼砂、鼠妇、三七研磨成600目细粉,并置于混合细粉5倍重量、体积分数为95%的乙醇溶液中浸泡30h,采用CO2超临界萃取技术分离上清液备用;
3)将合欢花、尖尾风、紫苏叶、两面针混合后加入混合物总重量10倍的水,水取自底下60-100米深的井水,水的pH值为7.0-8.0,武火煮沸后,保持沸腾状态2h,煎煮温度为95-100℃,过滤取煎煮液自然冷却后备用;
4)将独活、吕宋果、天仙子、红木香采用粉碎机粉碎后置于反应罐中,加入物料重量8倍的水,水取自底下60-100米深的井水,于80℃条件下熬制50h,熬制结束后过滤,取滤液,采用无菌灌装后,置于阴凉通风处保存15d备用;
5)将步骤2)中的上清液、步骤3)中的煎煮液以及步骤4)中的滤液混合浓缩,混合溶液以1000r/min的搅拌速度搅拌45min,搅拌过程中维持恒温60℃;混合液浓缩至原体积的1/5后,冷冻干燥,并粉碎研磨至300目,得本发明药物组合物,物组合物通过添加药学上常规辅料制备成用于治疗癌性疼痛的针剂。
实施例3
一种麻醉科用于治疗癌性疼痛的药物组合物,由以下按照重量份的原料制成:合欢花13份、尖尾风18份、紫苏叶6份、两面针8份、九香虫5份、独活9份、吕宋果5份、三七11份、天仙子9份、红木香9份、硼砂4份、鼠妇2份。
所述麻醉科用于治疗癌性疼痛的药物组合物的制备方法,包括以下步骤:
1)按配方称取各原料,洗净晾干后备用;
2)将九香虫、硼砂、鼠妇、三七研磨成400目细粉,并置于混合细粉3倍重量、体积分数为95%的乙醇溶液中浸泡24h,采用CO2超临界萃取技术分离上清液备用;
3)将合欢花、尖尾风、紫苏叶、两面针混合后加入混合物总重量7倍的水,水取自底下60-100米深的井水,水的pH值为7.0-8.0,武火煮沸后,保持沸腾状态1h,煎煮温度为95-100℃,过滤取煎煮液自然冷却后备用;
4)将独活、吕宋果、天仙子、红木香采用粉碎机粉碎后置于反应罐中,加入物料重量5倍的水,水取自底下60-100米深的井水,于65℃条件下熬制47h,熬制结束后过滤,取滤液,采用无菌灌装后,置于阴凉通风处保存7-15d备用;
5)将步骤2)中的上清液、步骤3)中的煎煮液以及步骤4)中的滤液混合浓缩,混合溶液以800r/min的搅拌速度搅拌35min,搅拌过程中维持恒温50℃;混合液浓缩至原体积的1/5后,冷冻干燥,并粉碎研磨至200目,得本发明药物组合物,物组合物通过添加药学上常规辅料制备成用于治疗癌性疼痛的针剂。
实施例4
一种麻醉科用于治疗癌性疼痛的药物组合物,由以下按照重量份的原料制成:合欢花17份、尖尾风22份、紫苏叶8份、两面针10份、九香虫7份、独活11份、吕宋果7份、三七19份、天仙子11份、红木香11份、硼砂6份、鼠妇4份。
所述麻醉科用于治疗癌性疼痛的药物组合物的制备方法,包括以下步骤:
1)按配方称取各原料,洗净晾干后备用;
2)将九香虫、硼砂、鼠妇、三七研磨成600目细粉,并置于混合细粉5倍重量、体积分数为95%的乙醇溶液中浸泡27h,采用CO2超临界萃取技术分离上清液备用;
3)将合欢花、尖尾风、紫苏叶、两面针混合后加入混合物总重量9倍的水,水取自底下60-100米深的井水,水的pH值为7.0-8.0,武火煮沸后,保持沸腾状态2h,煎煮温度为95-100℃,过滤取煎煮液自然冷却后备用;
4)将独活、吕宋果、天仙子、红木香采用粉碎机粉碎后置于反应罐中,加入物料重量7倍的水,水取自底下60-100米深的井水,于75℃条件下熬制49h,熬制结束后过滤,取滤液,采用无菌灌装后,置于阴凉通风处保存13d备用;
5)将步骤2)中的上清液、步骤3)中的煎煮液以及步骤4)中的滤液混合浓缩,混合溶液以1000r/min的搅拌速度搅拌40min,搅拌过程中维持恒温60℃;混合液浓缩至原体积的1/5后,冷冻干燥,并粉碎研磨至300目,得本发明药物组合物,物组合物通过添加药学上常规辅料制备成用于治疗癌性疼痛的外敷剂。
实施例5
一种麻醉科用于治疗癌性疼痛的药物组合物,由以下按照重量份的原料制成:合欢花15份、尖尾风20份、紫苏叶7份、两面针8份、九香虫6份、独活10份、吕宋果6份、三七15份、天仙子10份、红木香10份、硼砂5份、鼠妇3份。
所述麻醉科用于治疗癌性疼痛的药物组合物的制备方法,包括以下步骤:
1)按配方称取各原料,洗净晾干后备用;
2)将九香虫、硼砂、鼠妇、三七研磨成500目细粉,并置于混合细粉4倍重量、体积分数为95%的乙醇溶液中浸泡25h,采用CO2超临界萃取技术分离上清液备用;
3)将合欢花、尖尾风、紫苏叶、两面针混合后加入混合物总重量8倍的水,水取自底下60-100米深的井水,水的pH值为7.0-8.0,武火煮沸后,保持沸腾状态1.5h,煎煮温度为95-100℃,过滤取煎煮液自然冷却后备用;
4)将独活、吕宋果、天仙子、红木香采用粉碎机粉碎后置于反应罐中,加入物料重量6倍的水,水取自底下60-100米深的井水,于70℃条件下熬制48h,熬制结束后过滤,取滤液,采用无菌灌装后,置于阴凉通风处保存11d备用;
5)将步骤2)中的上清液、步骤3)中的煎煮液以及步骤4)中的滤液混合浓缩,混合溶液以900r/min的搅拌速度搅拌37min,搅拌过程中维持恒温55℃;混合液浓缩至原体积的1/5后,冷冻干燥,并粉碎研磨至300目,得本发明药物组合物,物组合物通过添加药学上常规辅料制备成用于治疗癌性疼痛的针剂。
上面对本专利的较佳实施方式作了详细说明,但是本专利并不限于上述实施方式,在本领域的普通技术人员所具备的知识范围内,还可以在不脱离本专利宗旨的前提下作出各种变化。
Claims (9)
1.一种麻醉科用于治疗癌性疼痛的药物组合物,其特征在于,由以下按照重量份的原料制成:合欢花10-20份、尖尾风15-25份、紫苏叶4-10份、两面针6-12份、九香虫4-8份、独活5-15份、吕宋果4-8份、三七10-20份、天仙子8-12份、红木香7-13份、硼砂4-6份、鼠妇1-5份。
2.根据权利要求1所述的麻醉科用于治疗癌性疼痛的药物组合物,其特征在于,由以下按照重量份的原料制成:合欢花13-17份、尖尾风18-22份、紫苏叶6-8份、两面针8-10份、九香虫5-7份、独活9-11份、吕宋果5-7份、三七11-19份、天仙子9-11份、红木香9-11份、硼砂4-6份、鼠妇2-4份。
3.根据权利要求1所述的麻醉科用于治疗癌性疼痛的药物组合物,其特征在于,由以下按照重量份的原料制成:合欢花15份、尖尾风20份、紫苏叶7份、两面针8份、九香虫6份、独活10份、吕宋果6份、三七15份、天仙子10份、红木香10份、硼砂5份、鼠妇3份。
4.根据权利要求1-3任一所述的麻醉科用于治疗癌性疼痛的药物组合物的制备方法,其特征在于,包括以下步骤:
1)按配方称取各原料,洗净晾干后备用;
2)将九香虫、硼砂、鼠妇、三七研磨成400-600目细粉,并置于混合细粉3-5倍重量、体积分数为95%的乙醇溶液中浸泡20-30h,采用CO2超临界萃取技术分离上清液备用;
3)将合欢花、尖尾风、紫苏叶、两面针混合后加入混合物总重量6-10倍的水,武火煮沸后,保持沸腾状态1-2h,过滤取煎煮液自然冷却后备用;
4)将独活、吕宋果、天仙子、红木香采用粉碎机粉碎后置于反应罐中,加入物料重量4-8倍的水,于60-80℃条件下熬制46-50h,熬制结束后过滤,取滤液备用;
5)将步骤2)中的上清液、步骤3)中的煎煮液以及步骤4)中的滤液混合浓缩,混合液浓缩至原体积的1/5后,冷冻干燥,并粉碎研磨至200-300目,得本发明药物组合物。
5.根据权利要求4所述的麻醉科用于治疗癌性疼痛的药物组合物的制备方法,其特征在于,所述步骤3)、步骤4)中的水取自底下60-100米深的井水。
6.根据权利要求5所述的麻醉科用于治疗癌性疼痛的药物组合物的制备方法,其特征在于,所述步骤3)中,煎煮温度为95-100℃,水的pH值为7.0-8.0。
7.根据权利要求4所述的麻醉科用于治疗癌性疼痛的药物组合物的制备方法,其特征在于,所述步骤4)中,滤液采用无菌灌装后,置于阴凉通风处保存7-15d备用。
8.根据权利要求4所述的麻醉科用于治疗癌性疼痛的药物组合物的制备方法,其特征在于,所述步骤5)中,混合溶液以800-1000r/min的搅拌速度搅拌30-45min,搅拌过程中维持恒温50-60℃。
9.根据权利要求1-4任一所述的麻醉科用于治疗癌性疼痛的药物组合物,其特征在于,所述药物组合物通过添加药学上常规辅料制备成用于治疗癌性疼痛的外敷剂或针剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610780070.2A CN106256359A (zh) | 2016-08-31 | 2016-08-31 | 一种麻醉科用于治疗癌性疼痛的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610780070.2A CN106256359A (zh) | 2016-08-31 | 2016-08-31 | 一种麻醉科用于治疗癌性疼痛的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106256359A true CN106256359A (zh) | 2016-12-28 |
Family
ID=57713693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610780070.2A Pending CN106256359A (zh) | 2016-08-31 | 2016-08-31 | 一种麻醉科用于治疗癌性疼痛的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106256359A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109248304A (zh) * | 2018-11-28 | 2019-01-22 | 李玉春 | 一种麻醉科用于治疗癌性疼痛的药物组合物 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102580000A (zh) * | 2012-03-21 | 2012-07-18 | 山东省千佛山医院 | 一种治疗癌性疼痛药物及其制备方法 |
CN102579505A (zh) * | 2012-03-21 | 2012-07-18 | 苏宏瑞 | 一种治疗癌性疼痛的药物及其制备方法 |
CN103083463A (zh) * | 2011-11-01 | 2013-05-08 | 陈光伟 | 癌痛贴 |
CN104147554A (zh) * | 2014-09-04 | 2014-11-19 | 耿建芳 | 一种治疗癌痛的中药药剂 |
CN104524075A (zh) * | 2014-12-10 | 2015-04-22 | 任立杰 | 治疗癌症疼痛的药物及其制备方法 |
CN104758447A (zh) * | 2015-04-24 | 2015-07-08 | 王守平 | 一种治疗胃癌疼痛的中药 |
-
2016
- 2016-08-31 CN CN201610780070.2A patent/CN106256359A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103083463A (zh) * | 2011-11-01 | 2013-05-08 | 陈光伟 | 癌痛贴 |
CN102580000A (zh) * | 2012-03-21 | 2012-07-18 | 山东省千佛山医院 | 一种治疗癌性疼痛药物及其制备方法 |
CN102579505A (zh) * | 2012-03-21 | 2012-07-18 | 苏宏瑞 | 一种治疗癌性疼痛的药物及其制备方法 |
CN104147554A (zh) * | 2014-09-04 | 2014-11-19 | 耿建芳 | 一种治疗癌痛的中药药剂 |
CN104524075A (zh) * | 2014-12-10 | 2015-04-22 | 任立杰 | 治疗癌症疼痛的药物及其制备方法 |
CN104758447A (zh) * | 2015-04-24 | 2015-07-08 | 王守平 | 一种治疗胃癌疼痛的中药 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109248304A (zh) * | 2018-11-28 | 2019-01-22 | 李玉春 | 一种麻醉科用于治疗癌性疼痛的药物组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103877247B (zh) | 用于治疗褥疮的药物及其制备方法 | |
CN106138733A (zh) | 一种治疗皮肤病的中药膏制剂及其制备方法 | |
CN102885997B (zh) | 一种治疗神经性皮炎的中药 | |
CN105031013A (zh) | 一种治疗腰椎骨质增生的药物及其制备方法 | |
CN104758897A (zh) | 益气养血补肾酒 | |
CN104623600A (zh) | 一种治疗末梢神经炎的中药及其制备方法 | |
CN108379385A (zh) | 一种治疗颈肩腰腿痛的中药制剂及其制备方法 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN106256359A (zh) | 一种麻醉科用于治疗癌性疼痛的药物组合物 | |
CN104306610A (zh) | 一种治疗胃酸过多的中药及其制备方法 | |
CN105079463A (zh) | 一种治疗心血管疾病的中药制剂及其制备方法 | |
CN101518579B (zh) | 一种稳压疏通药及制备工艺 | |
CN104352995A (zh) | 一种治疗胆结石的药物及其制备方法 | |
CN104825598A (zh) | 一种治疗风湿骨痛的外用膏药及其制备方法 | |
CN104352899A (zh) | 一种治疗慢性胃炎的中药制剂 | |
CN103550471A (zh) | 一种治疗痹痛的中药组合物 | |
CN105816737A (zh) | 一种治疗失眠的足浴配方 | |
CN105962352A (zh) | 一种保护男性前列腺的食药及其制备方法 | |
CN105456951A (zh) | 一种治疗乳房纤维腺瘤的中药制剂及其制备方法 | |
CN104524454A (zh) | 一种松筋藤镇痛酊 | |
CN105664024A (zh) | 一种治疗湿热困脾型胃脘痛的夏连合剂及制备方法 | |
CN105641273A (zh) | 一种桑寄生强筋骨除风湿足浴液及其制备方法 | |
CN104740193A (zh) | 一种治疗颈肩肌肉劳损综合症的中药组合物及其制备方法 | |
CN104474486A (zh) | 治疗急性胃炎的中药酒 | |
CN103816468B (zh) | 一种治疗胃癌的胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161228 |
|
RJ01 | Rejection of invention patent application after publication |